Cognitive stimulation in patients with Parkinson's Disease with cognitive impairment living in long-term care
Not Applicable
- Conditions
- G20Parkinson disease
- Registration Number
- DRKS00011776
- Lead Sponsor
- niversitätsklinik Köln, Medizinische Psychologie |Neuropsychologie und Gender Studies
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Clinical diagnosis conducted by neurologist or psychiatrist, mild to moderate dementia; Age: 50 years or older, mother tongue Dutch or very good skills in Dutch language; Good or sufficiently corrected vision and hearing
Exclusion Criteria
MMSE overall score below 10 points; Major depression (operationalized by the CDS >12) (Rasmus, 2009); Alcohol and drug abuse in the last three years; Acute suicidal tendencies, acute psychotic symptoms, other serious / life-threatening comorbidities that oppose study participation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cognition: times of measurement: Baseline, Posttest, Follow up (after 6 weeks) CERAD (+ Trail Making A+B, letter fluency), Clock Drawing Test
- Secondary Outcome Measures
Name Time Method Patient-Related Endpoints:<br><br>Quality of life: measuring instruments: EQ-5D-5L (self-administered), EQ-5D-5L (proxy-administered) Quality of Life in Dementia (Qualidem, proxy-administered)<br><br>Depression; Measuring instruments: geriatric depression scale (GDS, self-administered), Cornell depression scale (CDS, proxy-administered);<br><br>Behavioral and psychiatric symptoms; Measuring instrument: neuropsychiatric inventory (NPI, proxy-administered);<br><br>Activities of daily life (ADLs); Measuring instrument: Barthel Index (proxy-administered);<br><br>All endpoints are collected at the time of pre- and post-testing (short-term effect) and after 6 weeks (long-term effect)